Cargando…
A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma
Adamantinomatous craniopharyngioma (ACP) is the most common tumor of the sellar region in children. The aggressive behavior of ACP challenges the treatment for it. However, immunotherapy is rarely studied in ACP. In this research, we performed unsupervised cluster analysis on the 725 immune-related...
Autores principales: | Yuan, Feng, Cai, Xiangming, Zhu, Junhao, Yuan, Lei, Wang, Yingshuai, Tang, Chao, Cong, Zixiang, Ma, Chiyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710480/ https://www.ncbi.nlm.nih.gov/pubmed/34966342 http://dx.doi.org/10.3389/fneur.2021.704130 |
Ejemplares similares
-
Adamantinomatous craniopharyngioma: evolution in the management
por: Massimi, Luca, et al.
Publicado: (2023) -
Hub genes for early diagnosis and therapy of adamantinomatous craniopharyngioma
por: Zou, Yang-Fan, et al.
Publicado: (2022) -
Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment
por: Cai, Xiangming, et al.
Publicado: (2021) -
Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma
por: Martinez‐Barbera, Juan Pedro
Publicado: (2015) -
N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas
por: Yuan, Feng, et al.
Publicado: (2022)